Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal Transplantation

NCT00685061 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Renal Transplantation

Interventions

DRUG: Thymoglobulin
DRUG: Campath-1H
DRUG: Daclizumab

Sponsor

University of Miami